COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 549: Articles 5481-5490  | Next

Literature analysis of the efficacy of COVID-19 vaccinations
Hulsen, T.
10.1101/2022.12.24.22283835 — Posted: 2022-12-27
Study COVID-19 Severity of Patients Admitted to Emergency Room (ER) with Chest X-ray Images
Stubblefield, J., Saldivar, C., De Feria, A., Riddle, J., Shivkumar, A., Causey, J., Qualls, J., Fowler, J., Huang, X.
10.1101/2022.12.25.22283942 — Posted: 2022-12-27
A second update on mapping the human genetic architecture of COVID-19
The COVID-19 Host Genetics Initiative, , Ganna, A.
10.1101/2022.12.24.22283874 — Posted: 2022-12-27
Techniques for Developing Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots
Chen, J., Kuhn, L. A., Raschka, S.
10.1101/2022.12.26.521948 — Posted: 2022-12-27
Evaluation of the molecular diversity of Brazilian strains of the B.1.1 variant of SARS-CoV-2 used in vaccines
do Nascimento, I. A., da Silva, L. S., Santos, A. C. d. S., Felix, P. T.
10.1101/2022.12.23.521847 — Posted: 2022-12-27
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tamura, T., Ito, J., Uriu, K., Zahradnik, J., Kida, I., Nasser, H., Shofa, M., Oda, Y., Lytras, S., Nao, N., Itakura, Y., Deguchi, S., Suzuki, R., Wang, L., Begum, M. M., Tsuda, M., Kosugi, Y., Fujita, S., Yoshimatsu, K., Suzuki, S., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Yamamoto, Y., Nagamoto, T., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Fukuhara, T., Saito, A., Tanaka, S., Matsuno, K., Takayama, K., Sato, K.
10.1101/2022.12.27.521986 — Posted: 2022-12-27
Tissue protective role of Ganetespib in SARS-CoV-2-infected Syrian golden hamsters
Teixeira Alves, L. G., Baumgardt, M., Hoppe, J., Firsching, T. C., Adler, J. M., Mastrobuoni, G., Grobe, J., Hoenzke, K., Kempa, S., Gruber, A. D., Hocke, A. C., Trimpert, J., Wyler, E., Landthaler, M.
10.1101/2022.12.27.521979 — Posted: 2022-12-27
An alpaca-derived nanobody neutralizes the SARS-CoV-2 omicron variant
Modhiran, N., Lauer, S. M., Amarilla, A. A., Hewins, P., van den Broek, S. I. L., Low, Y. S., Thakur, N., Liang, B., Nieto, G. V., Jung, J., Paramitha, D., Isaacs, A., de Sng, J., Song, D., Jorgensen, J., Cheuquemilla, Y., Burger, J., Andersen, I. V., Himelreichs, J., Jara, R., MacLoughlin, R., Miranda-Chacon, Z., Chana-Cuevas, P., Kramer, V., Spahn, C. M. T., Mielke, T., Khromykh, A. A., Munro, T., Jones, M., Young, P. R., Chappell, K., Bailey, D., Kjaer, A., Herth, M. M., Jurado, K. A., Schwefel, D., Rojas-Fernandez, A., Watterson, D.
10.1101/2022.12.27.521990 — Posted: 2022-12-27
ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses
Hoffmann, M. A., Yang, Z., Huey-Tubman, K. E., Cohen, A. A., Gnanapragasam, P. N., Nakatomi, L. M., Storm, K. N., Moon, W. J., Lin, P. J., Bjorkman, P. J.
10.1101/2022.12.26.521940 — Posted: 2022-12-27
Prior infection- and/or vaccine-induced protection against Omicron BA.1, BA.2 and BA.4/BA.5-related hospitalisations in older adults: a test-negative case-control study in Quebec, Canada
Carazo, S., Skowronski, D. M., Brisson, M., Sauvageau, C., Brousseau, N., Fafard, J. M., Gilca, R., Talbot, D., Ouakki, M., Febriani, Y., Deceuninck, G., De Wals, P., De Serres, G.
10.1101/2022.12.21.22283740 — Posted: 2022-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).